AIMS/HYPOTHESIS: We evaluated diabetes-related pregnancy outcomes in a cohort of Spanish women in relation to their glucose tolerance status, prepregnancy BMI and other predictive variables. METHODS: The present paper is part of a prospective study to evaluate the impact of American Diabetes Association (2000) criteria in the Spanish population. A total of 9,270 pregnant women were studied and categorised as follows according to prepregnancy BMI quartiles and glucose tolerance status: (1) negative screenees; (2) false-positive screenees; (3) gestational diabetes mellitus (GDM) according to American Diabetes Association criteria only; and (4) GDM according to National Diabetes Data Group criteria (NDDG). We evaluated fetal macrosomia, Caesarean section and seven secondary outcomes as diabetes-related pregnancy outcomes. The population-attributable and population-prevented fractions of predictor variables were calculated after binary logistic regression analysis with multiple predictors. RESULTS: Both prepregnancy BMI and abnormal glucose tolerance categories were independent predictors of pregnancy outcomes. The upper quartile of BMI accounted for 23% of macrosomia, 9.4% of Caesarean section, 50% of pregnancy-induced hypertension and 17.6% of large-for-gestational-age newborns. In contrast, NDDG GDM accounted for 3.8% of macrosomia, 9.1% of pregnancy-induced hypertension and 3.4% of preterm births. CONCLUSIONS/ INTERPRETATION: In terms of population impact, prepregnancy maternal BMI exhibits a much stronger influence than abnormal blood glucose tolerance on macrosomia, Caesarean section, pregnancy-induced hypertension and large-for-gestational-age newborns.
AIMS/HYPOTHESIS: We evaluated diabetes-related pregnancy outcomes in a cohort of Spanish women in relation to their glucose tolerance status, prepregnancy BMI and other predictive variables. METHODS: The present paper is part of a prospective study to evaluate the impact of American Diabetes Association (2000) criteria in the Spanish population. A total of 9,270 pregnant women were studied and categorised as follows according to prepregnancy BMI quartiles and glucose tolerance status: (1) negative screenees; (2) false-positive screenees; (3) gestational diabetes mellitus (GDM) according to American Diabetes Association criteria only; and (4) GDM according to National Diabetes Data Group criteria (NDDG). We evaluated fetal macrosomia, Caesarean section and seven secondary outcomes as diabetes-related pregnancy outcomes. The population-attributable and population-prevented fractions of predictor variables were calculated after binary logistic regression analysis with multiple predictors. RESULTS: Both prepregnancy BMI and abnormal glucose tolerance categories were independent predictors of pregnancy outcomes. The upper quartile of BMI accounted for 23% of macrosomia, 9.4% of Caesarean section, 50% of pregnancy-induced hypertension and 17.6% of large-for-gestational-age newborns. In contrast, NDDG GDM accounted for 3.8% of macrosomia, 9.1% of pregnancy-induced hypertension and 3.4% of preterm births. CONCLUSIONS/ INTERPRETATION: In terms of population impact, prepregnancy maternal BMI exhibits a much stronger influence than abnormal blood glucose tolerance on macrosomia, Caesarean section, pregnancy-induced hypertension and large-for-gestational-age newborns.
Authors: B C Brost; R L Goldenberg; B M Mercer; J D Iams; P J Meis; A H Moawad; R B Newman; M Miodovnik; S N Caritis; G R Thurnau; S F Bottoms; A Das; D McNellis Journal: Am J Obstet Gynecol Date: 1997-08 Impact factor: 8.661
Authors: W Ricart; J López; J Mozas; A Pericot; M A Sancho; N González; M Balsells; R Luna; A Cortázar; P Navarro; O Ramírez; B Flández; L F Pallardo; A Hernández; J Ampudia; J M Fernández-Real; R Corcoy Journal: Diabetologia Date: 2005-05-12 Impact factor: 10.122
Authors: M I Schmidt; B B Duncan; A J Reichelt; L Branchtein; M C Matos; A Costa e Forti; E R Spichler; J M Pousada; M M Teixeira; T Yamashita Journal: Diabetes Care Date: 2001-07 Impact factor: 19.112
Authors: Kim E Innes; Sahiti Kandati; Kathryn L Flack; Parul Agarwal; Terry Kit Selfe Journal: J Womens Health (Larchmt) Date: 2016-02-25 Impact factor: 2.681
Authors: Ashleigh K Schneider; Shalem Y Leemaqz; Julia Dalton; Petra E Verburg; Ben W Mol; Gus A Dekker; Claire T Roberts; Jessica A Grieger Journal: Acta Diabetol Date: 2021-03-20 Impact factor: 4.280
Authors: Alison M Stuebe; Mark B Landon; Yinglei Lai; Catherine Y Spong; Marshall W Carpenter; Susan M Ramin; Brian Casey; Ronald J Wapner; Michael W Varner; Dwight J Rouse; Anthony Sciscione; Patrick Catalano; Margaret Harper; George Saade; Yoram Sorokin; Alan M Peaceman; Jorge E Tolosa Journal: Am J Obstet Gynecol Date: 2012-05-02 Impact factor: 8.661
Authors: Ravi Retnakaran; Chang Ye; Anthony J G Hanley; Philip W Connelly; Mathew Sermer; Bernard Zinman; Jill K Hamilton Journal: CMAJ Date: 2012-05-22 Impact factor: 8.262
Authors: Ravi Retnakaran; Ying Qi; Mathew Sermer; Philip W Connelly; Anthony J G Hanley; Bernard Zinman Journal: Clin Endocrinol (Oxf) Date: 2008-10-21 Impact factor: 3.478